Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-192,500
Closed -$1.18M 35
2022
Q3
$1.18M Buy
+192,500
New +$806K 0.51% 34
2021
Q4
Sell
-17,500
Closed -$1.85M 37
2021
Q3
$1.85M Buy
+17,500
New +$1.56M 0.65% 34
2019
Q2
Sell
-13,500
Closed -$547K 32
2019
Q1
$547K Buy
+13,500
New +$546K 0.26% 29

Other funds holding ALLK

Acuta Capital Partners's ALLK Position: Q4 2022 in Review

Acuta Capital Partners sold out of Allakos (ALLK) in Q4 2022, closing a stake of 192,500 shares — an estimated $1.18M sold.

Acuta Capital Partners first reported a position in ALLK in Q1 2019 and held it in 3 quarters. The position peaked at $1.85M in Q3 2021. 130 funds tracked by Wall St. Rank hold ALLK as of Q4 2022.

  • Acuta Capital Partners reported no remaining Allakos position as of Q4 2022 after selling out during the quarter.
  • Acuta Capital Partners sold 192,500 Allakos shares in Q4 2022, an estimated $1.18M.
  • Acuta Capital Partners first reported a position in Allakos in Q1 2019 and held it in 3 quarters.
  • Acuta Capital Partners's Allakos position peaked at $1.85M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Allakos as of Q4 2022.

Based on Acuta Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.